Successful Large-Animal Procedures Build Momentum Toward Planned Launch of the StereoCED™ Platform f

$6 Million in New Markets Tax Credit Financing for the Acquisition, Renovation, and Equipping of a T

Maxim Group analyst Anthony Vendetti maintains NeuroOne Medical Tech (NASDAQ:NMTC) with a Buy and

NeuroOne Medical Technologies Corporation (NMTC) Q3 2026 Earnings Call Transcript

NeuroOne Medical Technologies Corporation (NMTC) Q2 2026 Earnings Call Transcript

NeuroOne Medical Tech (NASDAQ:NMTC) reported quarterly losses of $(0.25) per share which missed the

First Choice Healthcare Solutions (OTCMKTS:FCHS - Get Free Report) and NeuroOne Medical Technologies

NeuroOne Medical Technologies Corporation (NMTC) Discusses Platform Technology Advancements and Grow

Shares of NeuroOne Medical Technologies Corporation (NASDAQ: NMTC - Get Free Report) have been given

Jones Trading analyst Justin Walsh initiates coverage on NeuroOne Medical Tech (NASDAQ:NMTC) with

NeuroOne Medical Technologies Corporation (NMTC) Q1 2026 Earnings Call Transcript

NeuroOne Medical Tech (NASDAQ:NMTC) reported quarterly losses of $(0.03) per share which beat the an

Aclarion (NASDAQ: ACON - Get Free Report) and NeuroOne Medical Technologies (NASDAQ: NMTC - Get Free

Cannlabs (OTCMKTS:CANL - Get Free Report) and NeuroOne Medical Technologies (NASDAQ: NMTC - Get Free

RIGL, CM and NMTC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on January 6th, 202

ILPT, NMTC, RIGL, RIO and BHP have been added to the Zacks Rank #1 (Strong Buy) List on January 6th,

NeuroOne Medical Technologies Corporation (NMTC) Q4 2025 Earnings Call Transcript

NeuroOne Medical Tech (NASDAQ:NMTC) reported quarterly losses of $(0.04) per share which met the ana

NeuroOne Medical Technologies Corporation - Special Call Company Participants David Rosa - President

 Preliminary Results On October 6, 2024, the Company reported the following preliminary unaudited fi

Maxim Group analyst Anthony Vendetti initiates coverage on NeuroOne Medical Tech (NASDAQ:NMTC) wi

EDEN PRAIRIE, Minn., Sept. 08, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (N

NeuroOne stock rallies after FDA clears its OneRF system, a minimally invasive solution targeting se

FDA Clearance Further Validates Technology Platform and Offers Alternatives to Pharmaceutical and In

Protalix BioTherapeutics, Inc. (PLX) Q3 2025 Earnings Call August 14, 2025 8:30 AM ET Company Partic

NeuroOne Medical Tech (NASDAQ:NMTC) affirms FY2025 sales outlook from $8.00 million-$10.00 million t

NeuroOne Medical Tech (NASDAQ:NMTC) reported quarterly losses of $(0.03) per share which beat the an

Completed Oversubscribed $8.2 Million Capital Raise; Funded Through At Least Fiscal Year 2026 EDEN P

EDEN PRAIRIE, Minn., July 31, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NA

EDEN PRAIRIE, Minn., July 31, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NA

Patient Treated with OneRF® Ablation System Previously Experienced up to 10 Seizures a DayEDEN PRAIR

NeuroOne Medical Tech (NASDAQ:NMTC) affirms FY2025 sales outlook from $8.00 million-$10.00 million t

NeuroOne Medical Tech (NASDAQ:NMTC) reported quarterly losses of $(0.07) per share. This is a 36.36

Ladenburg Thalmann analyst Jeff Cohen initiates coverage on NeuroOne Medical Tech (NASDAQ:NMTC) w